易點雲(02416.HK)委任富強金融資本為新合規顧問
格隆匯7月17日丨易點雲(02416.HK)宣佈,由於對費用調整存在分歧,公司與新百利融資有限公司已共同協定終止雙方訂立的日期為2022年2月15日的合規顧問協議。
董事會進一步宣佈,富強金融資本已根據上市規則第3A.27條獲委任為公司的新合規顧問,自2024年8月2日起生效,任期直至公司根據上市規則第3A.19條就其遵守上市規則第13.46條的規定將刊發的其首次上巿日期起計首個完整財政年度(即截至2024年12月31日止財政年度)的公司財務業績當日,或直至根據公司與富強金融資本訂立的合規顧問協議之協議條款予以終止為止(以較早者為準)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.